AnneS.RenteriaMD

Oncology • Mineola, NY

Hematologic Oncology

Site Director, Transplantation and Cellular Therapy Program at Perlmutter Cancer Center - Long Island, NY

Join to view full profile

Dr. Renteria is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Renteria's full profile

Already have an account?

Office
120 Mineola Blvd
Ste 500
Mineola, NY 11501
Phone+1 516-663-9500

Fax+1 516-663-4613

Summary

At NYU Langone Health - Long Island's Transplantation and Cellular Therapy Program, our team prioritizes patient access and exceptional patient care. I leverage my extensive experience in the field to expand stem cell transplant and cellular immunotherapy programs, while addressing complex challenges such as Graft-versus-Host disease.

The collaboration with researchers and dedication to innovative therapies underscore a commitment to enhancing patient outcomes. Strategic operations and a patient-centered approach drive the success of our endeavors. Fluent in Spanish, French, and Portuguese, I navigate multicultural environments effectively, ensuring diverse patient populations benefit from the latest advancements in Bone Marrow Transplantation and CAR-T cell therapies.

Anne S. Renteria - Medical Director, Acute Leukemia & Stem Cell Transplant and C

Versatile, goal oriented, and passionate about my work Experienced leader in Hematology Oncology, Adult Leukemia, CAR-T therapies and Bone Marrow Transplant

Education & Training

Icahn School of Medicine at Mount SinaiFellowship, Blood & Bone Marrow Transplant, 2012 - 2013
Maimonides Medical CenterFellowship, Hematology and Medical Oncology, 2009 - 2012
NYC Health & Hospitals/South Brooklyn HealthChief Residency, Internal Medicine, 2008 - 2009
NYC Health & Hospitals/South Brooklyn HealthResidency, Internal Medicine, 2006 - 2009
Jackson Health SystemPost-Doctoral Fellowship, 2004 - 2005
Faculdade de Medicina da Universidade Federal do Rio de JaneiroClass of 1996, MD, Cum Laude

Certifications & Licensure

IN State Medical License 2024 - 2025
MD State Medical License 2023 - 2025
NJ State Medical License 2023 - 2025
NY State Medical License 2012 - 2025
DC State Medical License 2023 - 2024
VA State Medical License 2022 - 2024
LA State Medical License 2023 - 2023
MA State Medical License 2013 - 2014
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Hematology
American Board of Internal Medicine Medical Oncology
Educational Commission for Foreign Medical GraduatesECFMG Certificate
Join now to see all

Awards, Honors, & Recognition

Reviewer Biology of Blood and Marrow Transplantation Journal
Reviewer BMJ Case Reports Journal
"Honor Your Doctor" Award The Mount Sinai Medical Center, New York, NY, 2013
Appointed Representative - Southeast Region of Brazil Global Burden of Disease Study, Rio de Janeiro, Brazil, 2001
Resident Representative elected by the Council of Resident Physicians University Hospital, Federal University of Rio de Janeiro, Brazil, 1999-2000
Medical Student Tutor Scholarship - UFRJ School of Medicine, Brazil Brazil's National Council for Research (CNPq), 1996
Scientific Initiation Scholarship - Undergraduate Research - CNPq Department of Neurogenesis, UFRJ, 1987
Join now to see all

Clinical Trials

Prospective Cohort for the Evaluation of Biomarkers Following HCT (BMT CTN 1202) Start of enrollment: 2013 Jun 01
Completed
Multicenter Study Of Natalizumab Plus Standard Steroid Treatment For High Risk Acute Graft-Versus-Host Disease Start of enrollment: 2016 Aug 01
Completed
Phase 2
A Dose-Finding Study of Vedolizumab for Treatment of Steroid-Refractory Acute Intestinal Graft-Versus-Host Disease (GvHD) in Participants Who Have Undergone Allogeneic Hematopoietic Stem Cell Transplantation (Allo-HSCT) Start of enrollment: 2017 Apr 28
Terminated
Phase 2
A Study Evaluating the Safety and Efficacy of Brexucabtagene Autoleucel (KTE-X19) in Adult Subjects With Relapsed/Refractory B-precursor Acute Lymphoblastic Leukemia (ZUMA-3) Start of enrollment: 2016 Mar 07
COMPLETED
PHASE1, PHASE2
Study of Effectiveness of Axicabtagene Ciloleucel Compared to Standard of Care Therapy in Patients With Relapsed/Refractory Diffuse Large B Cell Lymphoma Start of enrollment: 2018 Jan 25
COMPLETED
PHASE3
A Study of JNJ-67856633 in Participants With Non-Hodgkin's Lymphoma (NHL) and Chronic Lymphocytic Leukemia (CLL) Start of enrollment: 2019 Apr 03
ACTIVE_NOT_RECRUITING
PHASE1
A Study of JNJ-68284528, a Chimeric Antigen Receptor T Cell (CAR-T) Therapy Directed Against B-Cell Maturation Antigen (BCMA) in Participants With Relapsed or Refractory Multiple Myeloma Start of enrollment: 2018 Jun 29
Completed
Phase 1, Phase 2
Efficacy and Safety Study of bb2121 Versus Standard Regimens in Subjects With Relapsed and Refractory Multiple Myeloma (RRMM) Start of enrollment: 2019 Apr 16
Active, not recruiting
Phase 3
Study of bb21217 in Multiple Myeloma Start of enrollment: 2017 Aug 16
Completed
Phase 1
Dose Escalation Study of Talquetamab in Participants With Relapsed or Refractory Multiple Myeloma Start of enrollment: 2017 Dec 16
RECRUITING
PHASE1
Dose Escalation Study of Teclistamab, a Humanized BCMA*CD3 Bispecific Antibody, in Participants With Relapsed or Refractory Multiple Myeloma Start of enrollment: 2017 May 16
ACTIVE_NOT_RECRUITING
PHASE1
Selinexor, Carfilzomib, and Dexamethasone in Treating Patients With Relapsed or Refractory Multiple Myeloma Start of enrollment: 2014 Jun 12
RECRUITING
PHASE1
Elotuzumab in Autologous Stem Cell Transplantation (ASCT) and Lenalidomide Maintenance for Multiple Myeloma Start of enrollment: 2016 Jan 01
Completed
Phase 1
Pomalidomide in Combination With High Dose Dexamethasone and Oral Cyclophosphamide Start of enrollment: 2011 Nov 01
Completed
Phase 1, Phase 2
Phase II, Single-Center, Oral Panobinostat in Combination With Lenalidomide and Dexamethasone in Multiple Myeloma (MM) Start of enrollment: 2012 Jul 01
Completed
Phase 2
Continued, Long-Term Follow-Up and Lenalidomide Maintenance Therapy for Patients on BMT CTN 0702 Protocol (BMT CTN 07LT) Start of enrollment: 2015 Mar 01
Completed
Phase 3
Ixazomib In Combination With Cyclophosphamide And Dexamethasone for Newly Diagnosed AL Amyloidosis Start of enrollment: 2017 Jun 12
Completed
Phase 1, Phase 2
Treating Cancer-Related Fatigue Through Systematic Light Exposure (Light for Fatigue Study) Start of enrollment: 2015 Sep 01
Completed
Not Applicable
Tandem Autologous Stem Cell Transplantation in Treating Patients With Primary Systemic (AL) Amyloidosis Start of enrollment: 2000 Aug 01
Completed
Phase 2
Melphalan, Bortezomib, and Stem Cell Transplant in Treating Patients With Primary Systemic Amyloidosis Start of enrollment: 2008 Jun 01
Completed
Phase 2
Melphalan, Lenalidomide, and Dexamethasone in Treating Patients With Primary Systemic Amyloidosis Start of enrollment: 2008 May 01
Completed
Phase 2
S0115, High-Dose Melphalan and Autologous Peripheral Stem Cell Transplantation in Treating Patients With Multiple Myeloma or Primary Systemic Amyloidosis Start of enrollment: 2004 Jan 01
Completed
Phase 2
S1304, Carfilzomib and Dexamethasone for Treating Patients With Relapsed or Refractory Myeloma
COMPLETED
PHASE2
Join now to see all

Publications & Presentations

PubMed

Transplant Eligible and Ineligible Elderly Patients with AML-A Genomic Approach and Next Generation Questions.
Paul Sackstein, Alexis Williams, Rachel Zemel, Jennifer A Marks, Anne S Renteria
Biomedicines. 2024-04-29
1 citations
AML with BCR-ABL1 Fusion treated with Imatinib, a Hypomethylating Agent and Venetoclax.
Soon Khai Low, Suparna Nanua, Mehul Patel, Anne S Renteria
Leukemia Research Reports. 2022-01-01
Primary Extranodal NK/T-Cell Lymphoma Presenting as Neurolymphomatosis Involving Multiple Cranial Nerves: A Case Report.
Sharmila Ghosh, Jacques Azzi, Amy M Chan, Kambiz Nael, Anne S Renteria
Acta Haematologica. 2021-09-16

Books/Book Chapters

Atlas of Diagnostic Hematology
Chapter: Precursor Lymphoid Neoplasms
Teruya-Feldstein, J, Renteria AS, Najfeld VElsevier, Inc.2020
Mount Sinai Expert Guide: Oncology
Chapter: Acute graft-versus-host disease
Renteria AS, Ferrara JL, Levine JEJohn Wiley & Sons Ltd2019

Abstracts/Posters

Are we crazy? Building a successful acute leukemia and stem cell transplant program during the COVID-19 pandemic
Taylor Harrison, MHA, Morgan Fillet, BS, RN, Anne S. Renteria, MD, James Williams, MHA, Tandem Meetings | Transplantation & Cellular Therapy Meetings of ASTCT and CIBMTR, 2022
Implementation of an Acute Leukemia and Stem Cell Transplant Program through a Multidisciplinary Team Approach for Practice Change
Cassidy Smith, PA-C, Morgan Fillet, RN, BS, Martha Wright, PA-C, Julia Wuest, PA-C, Lauren Sheldon, BSN, RN, Kelsey Hawkins-Rusch, MS, RN, CNS, Maria Sbenghe, MD, Saad..., Tandem Meetings | Transplantation & Cellular Therapy Meetings of ASTCT and CIBMTR, 2022
Dose-Adjusted Intensive Chemotherapy is Safe and Tolerable in Older Patients with Ph-Negative Acute Lymphoblastic Leukemia
Renteria AS, Venugopal S, Marcellino B, Keyzner A, Kremyanskaya M, Bar-Nathan M, Najfeld V, Mascarenhas J, Tandem Meeting, Houston, Texas, 2/23/2019
Are two sites better than one? Sites of care and quality of myeloma treatment
Renteria AS, Jagannath S, Fei K, Lin S, Yagnik R, La L, Lni JJ, Bickel NA, Journal of Clinical Oncology, 2019
Racial and insurance disparities in multiple myeloma management in a referral center
Renteria AS, Jagannath S, Fei K, Lin S, Yagnik R, La L, Lin J, Bickell NA, Journal of Clinical Oncology, 2019
A Phase 1b Study of Intravenous Vedolizumab Plus Standard of Care for Graft-Versus-Host Disease Prophylaxis in Subjects Undergoing Allogeneic Hematopoietic Stem Cell T...
Chen YB, Devine S, Renteria AS, Mona A, Cutler C, Syed Q, Parfionaovas A, Chen C, Jansson J, American Society of Hematology, 60th Annual Meeting, San Diego, CA, 12/3/2018
Optimizing the use of trimethoprim-sulfamethoxazole for prevention of PCP and opportunistic infections in allogeneic hematopoietic cell transplant recipients
Baneman E, Kim N, Rana M, Renteria AS, Steinberg A, Jakubowski R, Yum K, Saunders P, Jacobs S, Journal of Clinical Oncology, 2018
Biomarkers predict graft-vs-host disease outcomes better than clinical response after one week of treatment
Major-Monfried H, Renteria AS, Ozbek U, Hartwell MJ, Pawarode A, Yanik GA, Ayuk F, Holer E, Efebera YA, Hogan WJ, QayedM, Hexner EO, Wudhikarn K, WolfI M, Ordemann R, ..., American Society of Hematology, 58th Annual Meeting, San Diego, CA, 12/4/2016
An early biomarker algorithm predicts lethal GVHD and survival after allogeneic hematopoietic cell transplantation
Hartwell MJ, Ozbek U, Holer E, Renteria AS, Major-Monfried H, Reddy P, Aziz M, Hogan WJ, Ayuk F, Efebera YA, Hexner EO, Bunworasate U, Qayed M, Ordemann R, Wölfl M, Mi..., American Society of Hematology, 58th Annual Meeting, San Diego, CA, 12/4/2016
Secondary graft failure in allogeneic stem cell transplantation for myelofibrosis - a single institution experience
Keyzner A, Zhao YA, Renteria AS, Malone AK, Osman K, Scigliano E, Steinberg A, Isola L, BBMT, 2015
Donor cell cardiac myeloid sarcoma following umbilical cord transplantation
Hayes CA, Isola L, Scigliano E, Osman K, Steinberg A, Keyzner A, Renteria AS, Petersen B, Malone A., BBMT, 2015
Bendamustine-Brentuximab: Bridging to Transplant
Steinberg A, Renteria AS, Scigliano E, Hayes C, Kane M, Osman K, Malone A, Keyzner A, Isola L, 2015 BMT Tandem Meetings, BBMT, 2015
Impact of immunosuppression on serum free light chains levels in AL amyloidosis patients undergoing serial heart transplantation followed by stem cell transplantation
Renteria AS, Sanchorawala V, Sloan IM, Quillen K, Ruberg FL, Meier-Ewert H, Berk J, Niehaus ED, Semigran MJ, Seldin DC, XIth International Symposium on Amyloidosis, Indianapolis, NI, 4/29/2014
Early detection of cardiac functional improvement by longitudinal systolic strain following treatment of light-chain (AL) cardiac amyloidosis
Salinaro F, Meier-Ewert HK, Miler EJ, Fu J, Sarosiek S, Sanchorawala V,Berk J, Sloan IM, Finn KT, Quillen K, Shelton A, Renteria AS, Seldin DC, Ruberg FL, XIVth International Symposium on Amyloidosis, Indianapolis, IN, 4/28/2014
A multidisciplinary Team Approach for Diagnosis and Treatment of Patients with AL Amyloidosis
Finn KT, Fennessey S, Shelton AC, Brauneis D, Techner T, Quilen K, Sloan IM, Renteria AS, Seldin DC, Sanchorawala V, 2014 BMT Tandem Meetings, Dallas, Texas, 2/26/2014
Reduced-intensity cord blood transplantation for Mycosis Fungoides
Renteria AS, Levitt J, Rosenzweig K, Grosskreutz C, 2013 International Cord Blood Symposium, San Francisco, CA, 6/6/2013
Oral Glutamine and Probiotics on Enteral Morbidity following ASCT for Plasma Cell Dyscrasia
Renteria AS, Jakubowski R, Rothwell A, Hayek C, Osman K, Malone AK, Jagannath S, Isola L, Chari A, 2013 BMT Tandem Meeting, ASBMT, Salt Lake City, Utah, 2/13/2013
Plasma cell leukemia presenting as hyperviscosity syndrome and treated with bortezomib, cyclophosphamide and dexamethasone
MYarovikova, AS Renteria, N Fromer, AB Chandra, New York Chapter, ACP, Annual Scientific Meeting, Albany, NY, 8/24/2012
Expression of BC200 RNA in peripheral blood of breast cancer patients
C Andaz, AS Renteria, J Mathew, R Hayon, W Solomon, P Borgen, T Jacob, American Society of Breast Surgeons 13th Annual Meeting, 5/6/2012
Outcome of locally advanced pancreatic cancer in a socio-economically challenged urban patient population
Renteria AS, B Holland, YHuang, J Cooper, B Donahue, American Radium Society 93rd Annual Meeting, Palm Beach, FL, 4/30/2011
Nafcillin-associated life threatening hypokalemia
M Hassan, D Godkar, Renteria A, S Niranjan, S Sinnapunayagam, Southern Regional Meeting, Journal of Investigative Medicine, 2008
Brazilian Global Burden of Disease
Gadelha AMJ, Renteria AS, Leite IC, Valente JG, Schramm IMA, Portela MC, ENSP/Fiocruz/Fensptec, 10/2002
Diabetes Mellitus Complications in the Global Burden of Disease - Brazil Study
Renteria AS, Gadelha AMJ, Valente JG, Schramm IMA, 5th Brazilian Epidemiology Congress, Curitiba, Brazil, 3/2002
Evaluation of quality of life indicators in adults with type 1 diabetes
Silva MO, Rodacki M, Zajdenverg L, Carvalhal RCA, Renteria AS, Oliveira JEP, XIII Brazilian Diabetes Congress, Rio de Janeiro, Brazil, 10/2001
Factors related to the occurrence of fetal macrossomia in children of women with gestational diabetes
Zadidenverg L, Renteria AS, Carvalhal RCA, Oliveira JEP, XIII Brazilian Diabetes Congress, Rio de Janeiro, Brazil, 10/2001
Join now to see all

Lectures

Twentv-Five Years of Advances in Hematology - Burham Lecture Series
Rochester Regional Hospital, Rochester, NY - 3/4/2021
Achieving quality Cell and Gene Therapies outcomes through multidisciplinary collaboration
ICON's multidisciplinary approach to CGT clinical trials - Global Webinar - 9/24/2020
Racial and insurance disparities in multiple myeloma management in a referral center.
ASCO Annual Meeting 2019 - Chicago, IL - 5/31/2019
Are two sites better than one?: Sites of care and quality of myeloma treatment.
ASCO Annual Meeting 2019 - Chicago, IL - 5/31/2019
AL amyloidosis
HEMO - Brazilian Meeting for Hematology, Hemotherapy, and Cellular Therapy, Rio de Janeiro, Brazil - 11/9/2019
Updates in treatment of AL amyloidosis
10th Franco-Brazilian Oncology Meeting, Rio de Janeiro, Brazil - 9/21/2018
Double-hit lymphomas: how to diagnose and treat?
10th Franco-Brazilian Oncology Meeting, Rio de Janeiro, Brazil - 9/21/2018
Diagnosis and treatment of AL amyloidosis
2nd International Symposium of the COI Institute, Rio de Janeiro, Brazil - 8/10/2018
Hematopoietic Cell Transplantation
Coney Island Hospital, NY - 5/10/2018
Race, Ethnicity and Outcomes of Allogeneic Hematopoietic Stem Cell Transplantation for Acute Lymphoblastic Leukemia in Hispanic Patients
2018 BMT Tandem Meeting, Salt Lake City, Utah - 2/24/2018
Acute Mveloid Leukemia in Adults and who to refer for allogeneic stem cell transplantation
Maimonides Medical Center, Brooklyn, NY - 4/12/2017
Update of treatment of Acute Lymphoblastic Leukemia
Maimonides Medical Center, Brooklyn, NY - 3/22/2017
Diagnosis and treatment of Acute Lymphoblastic Leukemia - role of transplantation
Brooklyn Hospital Center, NY - 4/12/2016
Diagnosis and treatment of AL amyloidosis - role of transplantation
Federal University of Rio de Janeiro, Brazil - 10/16/2014
Analysis of survival after first relapse post autologous stem cell transplant in Hodgkin's lymphoma
Hodgkin and Non-Hodgkin Lymphoma Working Committee of the CIBMTR - 2013 BMT Tandem Meeting - 2/14/2013
Join now to see all

Press Mentions

Perlmutter Cancer Center Appoints Renowned Clinician–Scientist to Lead Its Transplantation & Cellular Therapy Center on Long IslandDecember 20th, 2024

Committees

Member, BMT and Infectious Disease Committee - Mount Sinai Hospital 2017 - 2019
Member, Takeda - Vedolizumab-GHD Advisory Board Meeting 2017 - 2017
Member, Chemotherapy Council Committee - Mount Sinai Hospital 2016 - 2019
Member, Ethics Committee at the Rio de Janeiro Medicine Council (CREMERJ) - University Hospital, Federal University of Rio de Janeiro, Brazil 2000 - 2001
President, Association of Resident Physicians (AMERHU) - University Hospital Clementino Fraga Filho, Federal University of Rio de Janeiro, Brazil 1999 - 2000